Top compounds associated with response to LILRA2


Feature Type Standardized
Nominal ANOVA
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC -0.014 0.7
mRNA tivozanib CTRPv2 pan-cancer AAC 0.013 0.7
mRNA Vorinostat CTRPv2 pan-cancer AAC 0.012 0.7
mRNA KU-60019 CTRPv2 pan-cancer AAC -0.013 0.7
mRNA blebbistatin CTRPv2 pan-cancer AAC -0.025 0.7
mRNA StemRegenin 1 CTRPv2 pan-cancer AAC -0.012 0.7
mRNA PRIMA-1-Met CTRPv2 pan-cancer AAC 0.018 0.7
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.0097 0.7
mRNA ML203 CTRPv2 pan-cancer AAC 0.013 0.7
Download CSV